Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Nature Communications|October 27, 2011
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activityNicolas Léveillé, Ran Elkon, Veronica Davalos, et al.
Oxidative Medicine and Cellular Longevity|April 5, 2021
Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and <i>In Vitro</i> Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical CancerAkbar Pasha, Divya Vishambhar Kumbhakar, Ravinder Doneti, et al.
Plos Neglected Tropical Diseases|September 10, 2015
An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, IndiaVittal Mogasale, Shantanu K Kar, Jong-Hoon Kim, et al.
Gastrointestinal Endoscopy|October 23, 2022
Diagnostic yield and technical performance of the novel motorized spiral enteroscopy compared with single-balloon enteroscopy in suspected Crohn's disease: a prospective study (with video)Partha Pal, Piyush Vishwakarma, Aniruddha Pratap Singh, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Uptake during an oral cholera vaccine pilot demonstration program, Odisha, IndiaShantanu K Kar, Alfred Pach, Binod Sah, et al.
Nature Medicine|October 22, 2013
Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiologyTsuyoshi Udagawa, Natalie G Farny, Mira Jakovcevski, et al.
Gynecologic Oncology|April 19, 2021
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancerVijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical <i>Brca2</i>-deficient ovarian cancer modelYukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi, et al.
Scientific Reports|July 20, 2024
ChaQra: a cellular unit of the Indian quantum networkShashank Gupta, Iteash Agarwal, Vijayalaxmi Mogiligidda, et al.
Trials|December 14, 2021
Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controlsS Yogeshkumar, Jean Anderson, Enriquito Lu, et al.
Pageof 29